Christopher Fryer

6.8k total citations · 3 hit papers
54 papers, 4.4k citations indexed

About

Christopher Fryer is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Christopher Fryer has authored 54 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 14 papers in Oncology. Recurrent topics in Christopher Fryer's work include Sarcoma Diagnosis and Treatment (16 papers), Neuroblastoma Research and Treatments (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Christopher Fryer is often cited by papers focused on Sarcoma Diagnosis and Treatment (16 papers), Neuroblastoma Research and Treatments (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Christopher Fryer collaborates with scholars based in Canada, United States and Saudi Arabia. Christopher Fryer's co-authors include Sarah S. Donaldson, Paul S. Dickman, Mark Krailo, James S. Miser, Nancy J. Tarbell, Mark C. Gebhardt, Holcombe E. Grier, Paul A. Meyers, Douglas J. Pritchard and D.M. Hays and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and NeuroImage.

In The Last Decade

Christopher Fryer

54 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

2003 948 citations Holcombe E. Grier, Mark Krailo et al. profile →
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

2001 737 citations Christopher Fryer, R. Beverly Raney et al. Journal of Clinical Oncology profile →
The Third Intergroup Rhabdomyosarcoma Study.

1995 732 citations W M Crist, E. A. Gehan et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Fryer Canada	28	3.1k	1.1k	1.1k	1.1k	1.0k	54	4.4k
H. Jürgens Germany	40	3.4k 1.1×	1.1k 1.0×	1.2k 1.1×	1.0k 1.0×	1.2k 1.2×	138	5.4k
Peter S. Rose United States	44	2.6k 0.9×	1.1k 1.0×	3.8k 3.5×	1.6k 1.5×	1.8k 1.7×	294	7.5k
K. Helmke Germany	25	1.9k 0.6×	753 0.7×	1.1k 1.0×	299 0.3×	975 1.0×	83	4.6k
Robert E. Goldsby United States	31	1.5k 0.5×	617 0.6×	700 0.6×	500 0.5×	656 0.6×	94	3.6k
Gabriele Amann Austria	28	1.3k 0.4×	1.4k 1.3×	837 0.8×	404 0.4×	530 0.5×	125	3.5k
Cristiana Forni Italy	37	2.8k 0.9×	1.0k 0.9×	1.3k 1.2×	491 0.5×	1.4k 1.4×	106	4.4k
David A. Rodeberg United States	35	2.5k 0.8×	867 0.8×	1.2k 1.1×	1.1k 1.0×	726 0.7×	114	3.7k
Hélène Pacquement France	36	1.4k 0.5×	1.1k 1.0×	437 0.4×	1.1k 1.0×	304 0.3×	108	4.1k
G. Ulrich Exner Switzerland	26	2.5k 0.8×	842 0.8×	1.7k 1.5×	461 0.4×	1.3k 1.3×	136	4.4k
Florence C. H. Chu United States	35	1.8k 0.6×	1.2k 1.0×	1.4k 1.3×	497 0.5×	710 0.7×	88	4.5k

Countries citing papers authored by Christopher Fryer

Since Specialization

Citations

This map shows the geographic impact of Christopher Fryer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Fryer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Fryer more than expected).

Fields of papers citing papers by Christopher Fryer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Fryer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Fryer. The network helps show where Christopher Fryer may publish in the future.

Co-authorship network of co-authors of Christopher Fryer

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Fryer. A scholar is included among the top collaborators of Christopher Fryer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Fryer. Christopher Fryer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scantlebury, Nadia, Éric Bouffet, Suzanne Laughlin, et al.. (2016). White matter and information processing speed following treatment with cranial-spinal radiation for pediatric brain tumor.. Neuropsychology. 30(4). 425–438. 46 indexed citations

Vijarnsorn, Chodchanok, et al.. (2013). Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: A longitudinal study. Pediatric Blood & Cancer. 60(5). 842–848. 37 indexed citations

Fleming, Adam, Juliette Hukin, Shahrad R. Rassekh, et al.. (2011). Atypical Teratoid Rhabdoid Tumors (ATRTs): The British Columbia's Children's Hospital's Experience, 1986–2006. Brain Pathology. 22(5). 625–635. 21 indexed citations

Miser, James S., Robert E. Goldsby, Zhengjia Chen, et al.. (2007). Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group. Pediatric Blood & Cancer. 49(7). 894–900. 77 indexed citations

Yock, Torunn I., Mark Krailo, Christopher Fryer, et al.. (2006). Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 24(24). 3838–3843. 100 indexed citations

Fryer, Christopher, et al.. (2004). A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 43(6). 637–643. 28 indexed citations

Renaud, Fabrice G., Colin D. Brown, Christopher Fryer, & Allan Walker. (2004). A lysimeter experiment to investigate temporal changes in the availability of pesticide residues for leaching. Environmental Pollution. 131(1). 81–91. 43 indexed citations

Abbas, Adil, et al.. (2003). Factors influencing central line infections in children with acute lymphoblastic leukemia: Results of a single institutional study. Pediatric Blood & Cancer. 42(4). 325–331. 55 indexed citations

Abbas, Adil, et al.. (2001). Acute lymphoblastic leukemia presenting with extensive skeletal lesions and bone marrow necrosis. Medical and Pediatric Oncology. 37(1). 64–66. 6 indexed citations

10.

Smith, Sidney C., et al.. (2000). Extramedullary relapse in a child with mixed lineage acute lymphoblastic leukemia: Chylous pleuropericardial effusion. Medical and Pediatric Oncology. 34(4). 274–275. 5 indexed citations

11.

Shamberger, Robert C., Michael P. LaQuaglia, Mark Krailo, et al.. (2000). Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resection. Journal of Thoracic and Cardiovascular Surgery. 119(6). 1154–1161. 53 indexed citations

12.

Hutchinson, Ray, Christopher Fryer, P Davis, et al.. (1998). MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.. Journal of Clinical Oncology. 16(3). 897–906. 59 indexed citations

13.

Wharam, Moody D., John Hanfelt, Mariella C. Tefft, et al.. (1997). Radiation therapy for rhabdomyosarcoma: Local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. International Journal of Radiation Oncology*Biology*Physics. 38(4). 797–804. 52 indexed citations

14.

Kakadekar, Ashok, G Sándor, Christopher Fryer, et al.. (1997). Differences in dose scheduling as a factor in the etiology of anthracycline-induced cardiotoxicity in Ewing sarcoma patients. Medical and Pediatric Oncology. 28(1). 22–26. 17 indexed citations

15.

Donaldson, Sarah S., Lina Asmar, John C. Breneman, et al.. (1995). Hyperfractionated radiation in children with rhabdomyosarcoma—Results of an intergroup rhabdomyosarcoma pilot study. International Journal of Radiation Oncology*Biology*Physics. 32(4). 903–911. 38 indexed citations

16.

Crist, W M, E. A. Gehan, A H Ragab, et al.. (1995). The Third Intergroup Rhabdomyosarcoma Study.. Journal of Clinical Oncology. 13(3). 610–630. 732 indexed citations breakdown →

17.

Hays, Daniel M., Christopher Fryer, Kevin C. Pringle, et al.. (1992). An evaluation of abdominal staging procedures performed in pediatric patients with advanced Hodgkin's disease: A report from the childrens cancer study group. Journal of Pediatric Surgery. 27(9). 1175–1180. 10 indexed citations

18.

Gehan, E., M. P. Sullivan, Lillian M. Fuller, et al.. (1990). The intergroup Hodgkin's disease in children. A study of stages I and II. Cancer. 65(6). 1429–1437. 33 indexed citations

19.

Chan, Ka Wah, Christopher Fryer, Graham C. Fraser, & James E. Dimmick. (1985). Sudden cerebral death in malignant presacral teratoma. Medical and Pediatric Oncology. 13(6). 395–397. 1 indexed citations

20.

Fryer, Christopher, et al.. (1978). Radiation pneumonitis: Experience following a large single dose of radiation. International Journal of Radiation Oncology*Biology*Physics. 4(11-12). 931–936. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact